Research pen
Vasoactive Intestinal Peptide; 28-amino acid neuropeptide
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide composed of 28 amino acids. It is commonly utilised in laboratory research involving peptide structure, receptor-associated pathways, and cellular signalling systems. VIP belongs to the glucagon/secretin peptide family and is studied within a range of experimental biological models.
For laboratory and research use only. Pen illustration is a visual reference. Confirm the supplied format and batch details with our team.
VIP Pen, 10 mg selected.
A complete reference
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide composed of 28 amino acids. It is commonly utilised in laboratory research involving peptide structure, receptor-associated pathways, and cellular signalling systems. VIP belongs to the glucagon/secretin peptide family and is studied within a range of experimental biological models.
Vasoactive Intestinal Peptide was first identified in the intestinal tract and is widely distributed across multiple biological systems. In controlled research environments, VIP is used as a model compound in studies involving peptide interactions, receptor systems, and signalling pathway analysis.
Chemical reference information: CAS number: 40077-57-4; Molecular formula: C₁₄₇H₂₃₇N₄₃O₄₃S; Molecular weight: 3326.8 g/mol; Sequence: HSDAVFTDNYTRLRKQMAVKKYLNSILN. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
VIP 10 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.
Prepare a documentation requestContinue exploring
10 mg / 50 mg
5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule compound identified in scientific literature as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic pathways. NORVEXA research pen format.
Reference details
10 mg
ARA-290 (Cibinetide) is a synthetic peptide derived from the helix B domain of erythropoietin (EPO). NORVEXA research pen format.
Reference details
5 mg
AOD-9604 (Growth Hormone Fragment 177–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. NORVEXA research pen format.
Reference details